论文部分内容阅读
本文报道应用拉米夫定联合华蟾素治疗慢性乙型肝炎的疗效,以供参考。1 临床资料1.1 病例选择我院2000年10月-2002年10月就诊的慢性乙型肝炎患者。全部病例符合病毒性肝炎防治方案诊断标准。治疗组80例,其中男性58例,女性22例,年龄17~55岁,平均32.8岁。病程10个月~22年,平均5.8年。对照组80例与治疗组在性别、年龄、病程、肝功能改变及 HBV
This article reports the application of lamivudine combined with cinobufotalin in the treatment of chronic hepatitis B for reference. 1 Clinical data 1.1 Case Selection Our hospital from October 2000 to October 2002 treatment of chronic hepatitis B patients. All cases meet the diagnostic criteria of viral hepatitis prevention and treatment programs. Treatment group 80 cases, 58 males and 22 females, aged 17 to 55 years, mean 32.8 years old. Duration of 10 months to 22 years, an average of 5.8 years. The control group 80 cases and treatment group in gender, age, duration, changes in liver function and HBV